These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11911461)

  • 1. Refolding of the catalytic and hinge domains of human MT1-mMP expressed in Escherichia coli and its characterization.
    Koo HM; Kim JH; Hwang IK; Lee SJ; Kim TH; Rhee KH; Lee ST
    Mol Cells; 2002 Feb; 13(1):118-24. PubMed ID: 11911461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing.
    Osenkowski P; Meroueh SO; Pavel D; Mobashery S; Fridman R
    J Biol Chem; 2005 Jul; 280(28):26160-8. PubMed ID: 15901740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A; Kolkenbrock H; Tschesche H
    FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and refolding of recombinant human proMMP-7 (pro-matrilysin) expressed in Escherichia coli and its characterization.
    Itoh M; Masuda K; Ito Y; Akizawa T; Yoshioka M; Imai K; Okada Y; Sato H; Seiki M
    J Biochem; 1996 Apr; 119(4):667-73. PubMed ID: 8743567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale expression, refolding, and purification of the catalytic domain of human macrophage metalloelastase (MMP-12) in Escherichia coli.
    Parkar AA; Stow MD; Smith K; Panicker AK; Guilloteau JP; Jupp R; Crowe SJ
    Protein Expr Purif; 2000 Nov; 20(2):152-61. PubMed ID: 11049739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K; Lohi J; Valtanen H; Keski-Oja J
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
    J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
    Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
    J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
    Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
    J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
    Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
    J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
    Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y
    Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
    Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
    J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
    Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
    J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
    Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase.
    Toth M; Osenkowski P; Hesek D; Brown S; Meroueh S; Sakr W; Mobashery S; Fridman R
    Biochem J; 2005 Apr; 387(Pt 2):497-506. PubMed ID: 15560752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase.
    Wu YI; Munshi HG; Sen R; Snipas SJ; Salvesen GS; Fridman R; Stack MS
    J Biol Chem; 2004 Feb; 279(9):8278-89. PubMed ID: 14670950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
    d'Ortho MP; Will H; Atkinson S; Butler G; Messent A; Gavrilovic J; Smith B; Timpl R; Zardi L; Murphy G
    Eur J Biochem; 1997 Dec; 250(3):751-7. PubMed ID: 9461298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
    Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
    Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.